Clinical Trial Update: Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating berberine in combination with antiretroviral therapy for metabolic syndrome in people living with HIV; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Glucose Intolerance
• HIV Infection
• Lipoatrophy
• Lipodystrophy
• Metabolic Syndrome

Drugs mentioned

• Antiretroviral therapy
• Berberine (berberine)

Snippet

Sponsor: Hospital Civil de Guadalajara | Conditions: Metabolic Syndrome, HIV-1-infection | Phase 3 | Status: UNKNOWN